Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$169K Buy
+1,319
New +$154K 0.16% 225
2025
Q3
Sell
-2
Closed -$158 852
2025
Q2
$158 Sell
2
-3,074
-100% -$244K ﹤0.01% 711
2025
Q1
$276K Buy
3,076
+2,647
+617% +$247K 0.12% 319
2024
Q4
$42.7K Buy
+429
New +$44.2K 0.05% 493

Other funds holding MRK

Bayforest Capital's MRK Position: Q2 2026 in Review

Bayforest Capital opened a new position in Merck (MRK) in Q2 2026: 1,319 shares worth $169K. The stake represents 0.16% of the portfolio and ranks #225 among its holdings. This is a return to the name: Bayforest Capital previously reported a position in MRK as recently as Q2 2025.

Bayforest Capital first reported a position in MRK in Q4 2024 and has held it in 4 quarters since. The position peaked at $276K in Q1 2025. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Bayforest Capital held 1,319 shares of Merck worth $169K as of Q2 2026.
  • Merck was a new Bayforest Capital position in Q2 2026.
  • Merck made up 0.16% of Bayforest Capital's portfolio in Q2 2026, its #225 holding.
  • Bayforest Capital first reported a position in Merck in Q4 2024 and has held it in 4 quarters since.
  • Bayforest Capital's Merck position peaked at $276K in Q1 2025.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.